This process disrupts the PERK-CHOP pathway, reducing apoptosis and supporting AML cell survival under stress conditions, such as hypoxia and proteotoxicity in the bone marrow [78]. This evidence concerns the gene EIF2AK3 and acute myeloid leukemia.